[58]
In fact, Novopharm notes that the test for protective orders in cases under the
Regulations
focuses on the belief of the moving party as to the confidentiality of the information and the likelihood that its non-confidential release could cause harm to its interests. The question of whether there is a public interest in the information's disclosure is not the primary focus of the inquiry. The Federal Court of Appeal in
AB Hassle
and the Supreme Court of Canada in
Sierra Club
have already noted that there is a "relatively small public interest at stake" in cases under the
Regulations
.